期刊文献+

siRNA介导的Bmi-1基因沉默对乳腺癌细胞株MDA-MB-231侵袭迁移的影响 被引量:4

Effects of siRNA-mediated Bmi-1 silencing on invasion and metastasis of human mammary carcinoma cell line MDA-MB-231
下载PDF
导出
摘要 目的:利用小干扰RNA技术沉默Bmi-1基因的表达,探讨其对人乳腺癌细胞株MDA-MB-231侵袭转移能力的影响。方法:设计并化学合成了针对Bmi-1的小干扰RNA,转染具有高转移性的MDA-MB-231细胞,利用qRT-PCR和Western blot分别检测Bmi-1基因mRNA和蛋白的表达水平。体外通过Transwell小室、Matrigel胶模型﹑流式细胞术,观察Bmi-1被沉默后对乳腺癌细胞株MDA-MB-231生物学行为的影响。结果:qRT-PCR和Western结果显示,Bmi-1-siRNA转染组Bmi-1基因表达水平被有效抑制。与对照组相比,Bmi-1-siRNA转染组的细胞侵袭转移能力明显下降,细胞周期发生明显变化,细胞的增殖受到明显抑制。结论:抑制Bmi-1基因的表达可明显抑制MDA-MB-231细胞的侵袭迁移能力。 Objective:To investigate the effect of small interference RNA-mediated silencing of the Bmi-1 gene on cell invasion and metastasis in human mammary carcinoma cell line MDA-MB-231. Methods: Chemically synthesized siRNA targeting the Bmi-I gene was transfected into MDA-MB-231 cells, which have high invasive and metastatic potential. The expression of Bmi-1 mRNA and protein was detected by quantitave Real-time PCR and Western blot, respectively. The effect of Bmi-1 knockdown on MDA-MB-231 cells migration and invasion was analyzed by Transwell migration assay and Matrigel invasion assay. Results: Transfeetion with Bmi-I siRNA significantly down-regulated the expression of Bmi-1 RNA and protein as compared with the control group. MDA-MB-231 cells transfection with Bmi-1 siRNA had lower levels of invasion and migration capacity than cells in the control group. Conclusion: siRNA- mediated silencing of the Bmi-I gene could significantly inhibit cell migration and invasion in human breast cancer cell line MDA-MB- 231.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2014年第4期475-479,485,共6页 Chinese Journal of Immunology
基金 教育部高等学校博士学科点专项科研基金(20125503110012) 教育部高等学校博士学科点新教师基金项目(20115503120007) 重庆市自然科学基金项目(cstc2011jjA10035)
关键词 BMI-1 RNA干扰 侵袭 迁移 Bmi-1 RNA interference Invasion Migration
  • 相关文献

参考文献2

二级参考文献76

  • 1Schwartz YB and Pirrotta V. Polycomb complexes and epigenetic states. Curr Opin Cell Biol 2008, 20:266 273.
  • 2Orlando V. Polycomb, epigenomes, and control of cell identity. Cell 2003, 112:599 606.
  • 3Alkema MJ, Bronk M, Verhoeven E, Otte A, van't Veer LJ, Berns A and van Lohuizen M. Identification of Broil-interacting proteins as constituents of a multimeric mammalian polycomb complex. Genes Dev 1997, 11:226 240.
  • 4Itahana K, Zou Y, Itahana Y, Martinez JL, Beausejour C, Jacobs JJ and Van Lohuizen M, et al. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol 2003, 23:389 401.
  • 5Vonlanthen S, Heighway J, Altermatt H J, Gugger M, Kappeler A, Bomer MM and van Lohuizen M, et al. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 2001, 84:1372 1376.
  • 6Zhang F, Sui L and Xin T. Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues. Exp Oncol 2008, 30:70 74.
  • 7Sawa M, Yamaamoto K, Yokozawa T, Kiyoi H, Hishida A, Kajiguchi T and Seto M, et al. BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int J Hematol 2005, 82:42-47.
  • 8Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL and Shao JY, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006, 66: 6225-6232.
  • 9Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, Van Lohuizen M and Campisi J, et al. The Bmi-1 oncogene induces telo- merase activity and immortalizes human mammary epithelial cells.Cancer Res 2002, 62: 4736-4745.
  • 10Cui H, Hu B, Li T, Ma J, Alam G, Gunning WT and Ding HF. Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol 2007, 170: 1370-1378.

共引文献29

同被引文献66

  • 1Chen HH,Zhon It J, Fang X. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro [ J ]. Pharmacol Res, 2003,48 : 231-236.
  • 2Posner GH,Northrop J,Paik lH,et al. New chemical and biological aspects of artemisinin-dcrived trioxane dimmers [ J ]. Bioorg Med Chem,2012,10:227-232.
  • 3Li H, Song F, Chert X, Li Y,et al. Bmi-I regulates epithelial-to- mesencbymal transition to promote migration and invasion of breast cancer cells [ J ]. Int .I Clin Exp Patho1,2014,7 (6) :3057-3064.
  • 4Dooley AL, Winslow MM, Chiang DY, et al. Nuclear factor I/B is an oncogene in small cell lung cancer [ J ]. Genes Dev, 2011,25 : 1470-1475.
  • 5Raponi M, Zhang Y, Yu J, et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung[ J]. Cancer Res ,2006,66:7466-7472.
  • 6Yamachika E, Habte T, Oda D. Art emisinin: an alternative treatment for oral squamous cell carcinoma [ J]. Anticanccr Res, 2004,24:2153-2160.
  • 7Kim SJ, Kim MS, Lee JW, et al. Dihydroartemisinin enhances radi- osensitivity of human glioma ceils in vitro [ J ]. J Cancer Res Clin Onco1,2006,132 : 129-135.
  • 8Ruefli AA, Ausserlechner MJ, Bernhard D, et al. The histonedeacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell death pathway characterized by cleavage of Bid and production of reactive oxygen species [ J ]. Proc Natl Acad Sci USA, 2001,98 ( 19 ) : 10833-11838.
  • 9Allison AC, Cacabelos R, Lombardi VR, et al. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimers disease [ J ]. Prog Neuropsychopharmaeol Biol Psychiatry ,2001,25(7 ) :1341-1357.
  • 10Joensuu K, Hagstrim J, Leidenius M, et al. Bmi-l, c-myc, and Snail expression in priwary breast cancers and their metastases-elevated Bmi-1 expression in late breast cancer relapses [ J ]. Virchows Arch, 2011,459(1) : 31 -39.

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部